Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PHC signs second Innatus 3G deal

The US-based, UK-listed bioproducts company, Plant Health Care (PHC - Raleigh, North Carolina), has signed an agreement with a second unnamed "major industry player" to evaluate its Innatus 3G peptide platform. It allows the design, production and screening of a large pipeline of peptides with diverse biostimulant properties, PHC notes. They can be used for seed treatment and foliar applications for boosting disease resistance, drought tolerance and yield. PHC signed a similar deal in April. "Our goal was to sign at least two evaluation agreements for our Innatus 3G peptide platform this year and we have accomplished that within the first five months," says PHC's chief executive officer, Paul Schmidt. "We are targeting the largest players and these agreements reflect the potential value they see in our platform. Our dialogue with the other major players is ongoing."



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts